Top Markets
Coin of the day
Gelesis Holdings, Inc. Gelesis Holdings, Inc.

Gelesis Holdings, Inc.

GLS
Pozycja w akcjach #40696
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
Cena akcji
$0.0121
Ostatnia synchronizacja: 2023-05-23
Kapitalizacja rynkowa
$97.54K
Zmiana (1 dzień)
-24.38%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Gelesis Holdings, Inc. (GLS)

Kategoria

Historia ceny akcji dla Gelesis Holdings, Inc. (GLS)
Najwyższa cena zamknięcia: $0.01 dnia 2023-05-01

Najniższa cena zamknięcia: $5.55 dnia 2022-01-01
Historia cen akcji firmy Gelesis Holdings, Inc. od 2022 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 -95.27%
2022 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE